Last updated: February 26, 2025
Sponsor: Bogomolets National Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Erector Spinae Plane Block using 0.2% ropivacaine
Clinical Study ID
NCT06857331
190
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- impaired liver function - cirrhosis or chronic liver disease with the development ofhypocoagulation (APTT > 35 sec, INR > 1.5), thrombocytopenia, patients requiringmajor abdominal surgery, age > 18 years, written consent to participate in the studywas obtained
Exclusion
Exclusion Criteria:
- Platelet count <50x109, failed ESP catheterization unilateral or bilateral, failedepidural anesthesia attempt, history of allergy or hypersensitivity to localanesthetics, hepatopulmonary syndrome, patients on mechanical ventilation beforesurgery, patients on CRRT before surgery, refusal to participate in the study
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Erector Spinae Plane Block using 0.2% ropivacaine
Phase:
Study Start date:
May 05, 2024
Estimated Completion Date:
December 10, 2025
Connect with a study center
Universal Hospital Oberig
Kyiv,
UkraineActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.